Veracyte Inc (VCYT)
20.10
-0.92
(-4.38%)
USD |
NASDAQ |
May 08, 14:49
Veracyte Total Assets (Quarterly): 1.115B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.115B |
| September 30, 2023 | 1.125B |
| June 30, 2023 | 1.161B |
| March 31, 2023 | 1.157B |
| December 31, 2022 | 1.156B |
| September 30, 2022 | 1.126B |
| June 30, 2022 | 1.144B |
| March 31, 2022 | 1.174B |
| December 31, 2021 | 1.188B |
| September 30, 2021 | 1.186B |
| June 30, 2021 | 1.027B |
| March 31, 2021 | 1.025B |
| December 31, 2020 | 457.16M |
| September 30, 2020 | 454.15M |
| June 30, 2020 | 256.74M |
| March 31, 2020 | 267.10M |
| December 31, 2019 | 275.21M |
| September 30, 2019 | 260.31M |
| June 30, 2019 | 252.38M |
| March 31, 2019 | 123.54M |
| December 31, 2018 | 120.64M |
| September 30, 2018 | 119.08M |
| Date | Value |
|---|---|
| June 30, 2018 | 65.46M |
| March 31, 2018 | 71.19M |
| December 31, 2017 | 78.67M |
| September 30, 2017 | 83.66M |
| June 30, 2017 | 88.35M |
| March 31, 2017 | 92.61M |
| December 31, 2016 | 101.03M |
| September 30, 2016 | 69.65M |
| June 30, 2016 | 74.83M |
| March 31, 2016 | 84.27M |
| December 31, 2015 | 75.25M |
| September 30, 2015 | 80.85M |
| June 30, 2015 | 82.50M |
| March 31, 2015 | 55.06M |
| December 31, 2014 | 64.84M |
| September 30, 2014 | 71.81M |
| June 30, 2014 | 67.75M |
| March 31, 2014 | 72.45M |
| December 31, 2013 | 79.63M |
| September 30, 2013 | 23.57M |
| June 30, 2013 | 27.16M |
| December 31, 2012 | 19.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
252.38M
Minimum
Jun 2019
1.188B
Maximum
Dec 2021
832.00M
Average
1.115B
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Fonar Corp | 202.26M |
| XWELL Inc | 38.99M |
| ProPhase Labs Inc | 91.93M |
| Applied DNA Sciences Inc | 9.913M |
| OncoCyte Corp | 74.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 70.80M |
| Shareholders Equity (Quarterly) | 1.044B |
| Current Ratio | 4.664 |
| Net Debt Paydown Yield | 0.01% |